Synthesis and in-vitro/in-vivo evaluation of orally administered entacapone prodrugs. 2001

J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
Department of Pharmaceutical Chemistry, University of Kuopio, Finland. jukka.leppanen@uku.fi

Entacapone is a new inhibitor of catechol-O-methyltransferase (COMT) that is used as an adjunct to L-dopa therapy in the treatment of Parkinson's disease. The bioavailability of orally administered entacapone is, however, relatively low (29-46%). In this study we have prepared more lipophilic acyl and acyloxyacyl esters, an acyloxy alkyl ether and an alkyloxycarbonyl ester of entacapone, and we have evaluated them as potential prodrugs to enhance the oral bioavailability of entacapone. All the derivatives fulfilled prodrug criteria and released entacapone in human serum in-vitro. The oral bioavailability of monopivaloyl (1a) and dipivaloyl (1b) esters of entacapone were investigated further in rats. The lipophilicity of 1b was high (log Papp 4.0 at pH 7.4) but its oral bioavailability was low (F = 0.6%), most probably due to its low aqueous solubility. The monopivaloyl ester of entacapone (1a) had a higher lipophilicity (log Papp 0.80) than entacapone (log Papp 0.18) at pH 7.4 while maintaining an aqueous solubility equal to entacapone. However, oral bioavailability was not increased when compared with the parent drug entacapone (F = 7.0% and 10.4%, respectively).

UI MeSH Term Description Entries
D008297 Male Males
D008563 Membrane Lipids Lipids, predominantly phospholipids, cholesterol and small amounts of glycolipids found in membranes including cellular and intracellular membranes. These lipids may be arranged in bilayers in the membranes with integral proteins between the layers and peripheral proteins attached to the outside. Membrane lipids are required for active transport, several enzymatic activities and membrane formation. Cell Membrane Lipid,Cell Membrane Lipids,Membrane Lipid,Lipid, Cell Membrane,Lipid, Membrane,Lipids, Cell Membrane,Lipids, Membrane,Membrane Lipid, Cell,Membrane Lipids, Cell
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D002396 Catechols A group of 1,2-benzenediols that contain the general formula R-C6H5O2. Pyrocatechols,o-Dihydroxybenzenes,ortho-Dihydroxybenzenes,o Dihydroxybenzenes,ortho Dihydroxybenzenes
D004952 Esters Compounds derived from organic or inorganic acids in which at least one hydroxyl group is replaced by an –O-alkyl or another organic group. They can be represented by the structure formula RCOOR’ and are usually formed by the reaction between an acid and an alcohol with elimination of water. Ester
D004987 Ethers Organic compounds having two alkyl or aryl groups bonded to an oxygen atom, as in the formula R1–O–R2.
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.

Related Publications

J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
November 1994, Arzneimittel-Forschung,
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
May 1994, Journal of pharmaceutical sciences,
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
February 1992, Farmaco (Societa chimica italiana : 1989),
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
March 2011, Journal of medicinal chemistry,
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
January 1987, Drug metabolism and disposition: the biological fate of chemicals,
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
June 2024, Chemistry & biodiversity,
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
January 2000, Life sciences,
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
November 2012, European journal of medicinal chemistry,
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
August 1955, Journal of the American Geriatrics Society,
J Leppänen, and J Savolainen, and T Nevalainen, and M Forsberg, and J Huuskonen, and H Taipale, and J Gynther, and P T Männistö, and T Järvinen
February 2007, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!